A Study to Test How Kidney Problems Influence the Blood Concentrations of Efgartigimod

Clinical trial NCT05927415 · COMPLETED

Trial details

NCT number: NCT05927415
Sponsor: argenx
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Renal Impairment

Start date: 2023-07-17
Primary completion: 2024-06-12
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.